A review of Donnai-Barrow and facio-oculo-acoustico-renal (DB/FOAR) syndrome: clinical features and differential diagnosis

Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):76-81. doi: 10.1002/bdra.20534.

Abstract

Mutations in the gene LRP2 have recently been identified as the cause of Donnai-Barrow and Facio-oculo-acoustico-renal (DB/FOAR) syndrome. More than two dozen cases, the first reported more than 30 years ago by Holmes, have been published. Summarizing available information, we highlight the cardinal features of the disorder found in >or=90% of published cases. These features include: agenesis of the corpus callosum, developmental delay, enlarged anterior fontanelle, high myopia, hypertelorism, proteinuria, and sensorineural hearing loss. Congenital diaphragmatic hernia and omphalocele are reported in only half of the patients. There is no evidence for genotype-phenotype correlation, though the sample size is too small to preclude this with certainty. Although several conditions to consider in the differential diagnosis are highlighted, the diagnosis of DB/FOAR syndrome should not be difficult to establish as its constellation of findings is strikingly characteristic.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Abnormalities, Multiple* / diagnosis
  • Abnormalities, Multiple* / genetics
  • Abnormalities, Multiple* / physiopathology
  • Adolescent
  • Child
  • Child, Preschool
  • Craniofacial Abnormalities* / diagnosis
  • Craniofacial Abnormalities* / genetics
  • Developmental Disabilities / diagnosis
  • Developmental Disabilities / genetics
  • Diagnosis, Differential
  • Female
  • Hearing Loss, Sensorineural* / diagnosis
  • Hearing Loss, Sensorineural* / genetics
  • Humans
  • Infant
  • Infant, Newborn
  • Low Density Lipoprotein Receptor-Related Protein-2 / genetics
  • Male
  • Myopia* / diagnosis
  • Myopia* / genetics
  • Proteinuria* / diagnosis
  • Proteinuria* / genetics
  • Syndrome
  • Young Adult

Substances

  • Low Density Lipoprotein Receptor-Related Protein-2